vs
Side-by-side financial comparison of Insulet Corporation (PODD) and STAR GROUP, L.P. (SGU). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $539.3M, roughly 1.5× STAR GROUP, L.P.). Insulet Corporation runs the higher net margin — 13.0% vs 6.6%, a 6.3% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 10.5%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $-59.7M).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
Lone Star Funds, legal name of main entity Lone Star Global Acquisitions, Ltd. is a global private equity firm that invests in corporate equity, real estate, credit, and other financial assets. The founder of Lone Star established its first fund in 1995 and Lone Star has to date organized 25 private equity funds with total capital commitments since inception of over $95 billion. Lone Star's investors include corporate and public pension funds, sovereign wealth funds, university endowments, fo...
PODD vs SGU — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $783.7M | $539.3M |
| Net Profit | $101.6M | $35.8M |
| Gross Margin | 72.6% | — |
| Operating Margin | 18.7% | 10.1% |
| Net Margin | 13.0% | 6.6% |
| Revenue YoY | 31.2% | 10.5% |
| Net Profit YoY | 0.9% | 8.8% |
| EPS (diluted) | $1.42 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $783.7M | $539.3M | ||
| Q3 25 | $706.3M | — | ||
| Q2 25 | $649.1M | — | ||
| Q1 25 | $569.0M | — | ||
| Q4 24 | $597.5M | — | ||
| Q3 24 | $543.9M | — | ||
| Q2 24 | $488.5M | — | ||
| Q1 24 | $441.7M | — |
| Q4 25 | $101.6M | $35.8M | ||
| Q3 25 | $87.6M | — | ||
| Q2 25 | $22.5M | — | ||
| Q1 25 | $35.4M | — | ||
| Q4 24 | $100.7M | — | ||
| Q3 24 | $77.5M | — | ||
| Q2 24 | $188.6M | — | ||
| Q1 24 | $51.5M | — |
| Q4 25 | 72.6% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 69.7% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 72.1% | — | ||
| Q3 24 | 69.3% | — | ||
| Q2 24 | 67.7% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 18.7% | 10.1% | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 18.7% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 16.2% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 12.9% | — |
| Q4 25 | 13.0% | 6.6% | ||
| Q3 25 | 12.4% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 6.2% | — | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 14.2% | — | ||
| Q2 24 | 38.6% | — | ||
| Q1 24 | 11.7% | — |
| Q4 25 | $1.42 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $0.32 | — | ||
| Q1 25 | $0.50 | — | ||
| Q4 24 | $1.38 | — | ||
| Q3 24 | $1.08 | — | ||
| Q2 24 | $2.59 | — | ||
| Q1 24 | $0.73 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $19.9M |
| Total DebtLower is stronger | $930.8M | $254.8M |
| Stockholders' EquityBook value | $1.5B | — |
| Total Assets | $3.2B | $1.1B |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $19.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $930.8M | $254.8M | ||
| Q3 25 | $934.9M | — | ||
| Q2 25 | $939.0M | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $998.4M | — | ||
| Q1 24 | $790.7M | — |
| Q4 25 | $3.2B | $1.1B | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.5B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $2.9B | — | ||
| Q1 24 | $2.6B | — |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 1.72× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $183.3M | $-55.2M |
| Free Cash FlowOCF − Capex | $48.2M | $-59.7M |
| FCF MarginFCF / Revenue | 6.2% | -11.1% |
| Capex IntensityCapex / Revenue | 17.2% | 0.8% |
| Cash ConversionOCF / Net Profit | 1.80× | -1.54× |
| TTM Free Cash FlowTrailing 4 quarters | $377.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.3M | $-55.2M | ||
| Q3 25 | $125.7M | — | ||
| Q2 25 | $196.5M | — | ||
| Q1 25 | $63.8M | — | ||
| Q4 24 | $147.7M | — | ||
| Q3 24 | $98.5M | — | ||
| Q2 24 | $96.5M | — | ||
| Q1 24 | $87.6M | — |
| Q4 25 | $48.2M | $-59.7M | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | $177.9M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $94.1M | — | ||
| Q3 24 | $71.8M | — | ||
| Q2 24 | $74.0M | — | ||
| Q1 24 | $65.5M | — |
| Q4 25 | 6.2% | -11.1% | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 27.4% | — | ||
| Q1 25 | 9.1% | — | ||
| Q4 24 | 15.7% | — | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 14.8% | — |
| Q4 25 | 17.2% | 0.8% | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 1.80× | -1.54× | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 8.73× | — | ||
| Q1 25 | 1.80× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 0.51× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
SGU
| Home Heating Oil And Propane | $372.6M | 69% |
| Motor Fuel And Other Petroleum Products | $75.4M | 14% |
| Equipment Installations | $39.6M | 7% |
| Equipment Maintenance Service Contracts | $30.3M | 6% |
| Billable Call Services | $21.4M | 4% |